Minimal Access Surgical Technique (MAST) in Obese Patients in Degenerative

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

Being confronted more and more with obese as well as older patients, minimally invasive surgery is said to keep the surgical trauma low. The prospective long-term evaluation is the continuous monitoring of patients undergoing lumbar minimally invasive fusion surgery and analyzing the effect of body mass index (BMI) and wound healing.

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04130035` - Decision Making in Degenerative Lumbar Spine : CT vs. MRI
Completed	`NCT01195584` - Minimal Access Surgical Technique (MAST) in Obese Patients in Degenerative Lumbar Disease	N/A
Enrolling by invitation	`NCT05981222` - Osteo Match Cages Versus PEEK Cages in Osteoporotic Patients

NCT number	NCT01259960
Study type	Observational
Source	General Hospital Amstetten
Contact
Status	Completed
Phase	N/A
Start date	February 2011
Completion date	February 2017

Minimal Access Surgical Technique (MAST) in Obese Patients in Degenerative Lumbar Disease. A Prospective Long-term Evaluation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms